27834480|t|A Caucasian JK*A/JK*B woman with Jk(a+b-) red blood cells, anti-Jkb, and a novel JK*B allele c.1038delG
27834480|a|The Kidd blood group on the red blood cell (RBC) glycoprotein urea transporter-B has a growing number of weak and null alleles in its gene SLC14A1 that are emerging from more widespread genotyping of blood donors and patients. We investigated a 64-year-old Caucasian woman of Polish-Czech descent who developed anti-Jkb detected in solid-phase RBC adherence testing within 12 days after 7 units of RBCs were transfused. Her RBCs subsequently typed Jk(a+b–) by licensed reagents and human antisera. Nevertheless, in RBC genotyping (BioArray HEA BeadChip, Immucor, Warren, NJ) performed in our transfusion service on all patients with alloantibodies, her Kidd typing was JK*A/JK*B based on the Jka/Jkb single nucleotide polymorphism in exon 9 (c.838G>A, p.Asp280Asn). Genomic analysis and cDNA sequencing of her JK*B allele revealed a novel single-nucleotide deletion of c.1038G in exon 11, predicting a frameshift and premature stop (p.Thr346Thrfs*5) after translation of nearly 90 percent of the expressed exons 4–11. This allele has been provisionally named JK*02N.14, subject to approval by the International Society of Blood Transfusion Working Party. The site of this variant is closer to the C-terminus than that of any allele associated with the Jk(a–b–) phenotype reported to date. Routine genotyping of patients with RBC alloantibodies can reveal variants posing potential risk of alloimmunization. Continuing investigation of Kidd variants may shed light on the structure of Kidd antigens and the function of urea transporter-B.
27834480	2	11	Caucasian	T098	C0043157
27834480	12	21	JK*A/JK*B	T033	C4017339
27834480	22	27	woman	T098	C0043210
27834480	33	41	Jk(a+b-)	T032	C1320565
27834480	42	57	red blood cells	T025	C0014792
27834480	59	67	anti-Jkb	T116,T129	C0432654
27834480	81	103	JK*B allele c.1038delG	T028	C0017337
27834480	108	124	Kidd blood group	T022	C0022645
27834480	132	146	red blood cell	T025	C0014792
27834480	148	151	RBC	T025	C0014792
27834480	153	165	glycoprotein	T116,T123	C0017968
27834480	166	184	urea transporter-B	T116,T123	C1454327
27834480	199	205	number	T081	C0237753
27834480	209	213	weak	T080	C1762617
27834480	218	230	null alleles	T049	C2985437
27834480	238	250	gene SLC14A1	T028	C1420098
27834480	279	289	widespread	T082	C0205391
27834480	290	300	genotyping	T059	C1285573
27834480	304	316	blood donors	T098	C0005795
27834480	321	329	patients	T101	C0030705
27834480	334	346	investigated	T169	C1292732
27834480	361	370	Caucasian	T098	C0043157
27834480	371	376	woman	T098	C0043210
27834480	380	392	Polish-Czech	T098	C1257890
27834480	393	400	descent	T099	C0680043
27834480	415	423	anti-Jkb	T116,T129	C0432654
27834480	424	432	detected	T033	C0442726
27834480	436	447	solid-phase	T059	C3825034
27834480	448	451	RBC	T025	C0014792
27834480	452	461	adherence	T169	C1510802
27834480	462	469	testing	T169	C0039593
27834480	493	498	units	T081	C0439148
27834480	502	506	RBCs	T025	C0014792
27834480	512	522	transfused	T061	C1879316
27834480	528	532	RBCs	T025	C0014792
27834480	546	551	typed	T059	C0005844
27834480	552	560	Jk(a+b–)	T032	C1320565
27834480	564	572	licensed	T170	C1548573
27834480	573	581	reagents	T130	C0034760
27834480	586	591	human	T016	C0086418
27834480	592	600	antisera	T116,T129,T130	C0301462
27834480	619	622	RBC	T025	C0014792
27834480	623	633	genotyping	T059	C1285573
27834480	635	677	BioArray HEA BeadChip, Immucor, Warren, NJ	T170	C0282574
27834480	679	688	performed	T169	C0884358
27834480	696	707	transfusion	T061	C1879316
27834480	708	715	service	T058	C0011929
27834480	723	731	patients	T101	C0030705
27834480	737	751	alloantibodies	T129	C0022144
27834480	757	768	Kidd typing	T059	C0522936
27834480	773	782	JK*A/JK*B	T033	C4017339
27834480	796	803	Jka/Jkb	T028	C0017337
27834480	804	834	single nucleotide polymorphism	T086	C0752046
27834480	838	844	exon 9	T114,T123	C0015295
27834480	846	867	c.838G>A, p.Asp280Asn	T114,T123	C0015295
27834480	870	886	Genomic analysis	T091	C0887950
27834480	891	895	cDNA	T114	C0006556
27834480	896	906	sequencing	T059	C1294197
27834480	914	925	JK*B allele	T028	C0017337
27834480	926	934	revealed	T080	C0443289
27834480	943	969	single-nucleotide deletion	T049	C0544883
27834480	973	991	c.1038G in exon 11	T114,T123	C0015295
27834480	993	1003	predicting	T078	C0681842
27834480	1006	1016	frameshift	T049	C0079380
27834480	1021	1035	premature stop	T086	C0242612
27834480	1037	1052	p.Thr346Thrfs*5	T086	C0242612
27834480	1060	1071	translation	T045	C1519614
27834480	1085	1092	percent	T081	C0439165
27834480	1100	1109	expressed	T045	C0017262
27834480	1110	1120	exons 4–11	T114,T123	C0015295
27834480	1127	1133	allele	T028	C0002085
27834480	1143	1162	provisionally named	UnknownType	C0680886
27834480	1163	1172	JK*02N.14	T170	C1953359
27834480	1174	1181	subject	T169	C1550501
27834480	1185	1193	approval	T080	C0205540
27834480	1201	1243	International Society of Blood Transfusion	T170	C1550215
27834480	1244	1257	Working Party	T057	C0043227
27834480	1263	1267	site	T082	C0205145
27834480	1276	1283	variant	T070	C0042333
27834480	1287	1293	closer	T033	C3810854
27834480	1329	1335	allele	T028	C0002085
27834480	1336	1351	associated with	T080	C0332281
27834480	1356	1374	Jk(a–b–) phenotype	T034	C1292238
27834480	1375	1383	reported	T170	C0684224
27834480	1393	1400	Routine	T080	C0205547
27834480	1401	1411	genotyping	T059	C1285573
27834480	1415	1423	patients	T101	C0030705
27834480	1429	1432	RBC	T025	C0014792
27834480	1433	1447	alloantibodies	T129	C0022144
27834480	1452	1458	reveal	T080	C0443289
27834480	1459	1467	variants	T070	C0042333
27834480	1475	1484	potential	T080	C3245505
27834480	1485	1489	risk	T078	C0035647
27834480	1493	1509	alloimmunization	T047	C0948201
27834480	1511	1521	Continuing	T078	C0549178
27834480	1522	1535	investigation	T169	C1292732
27834480	1539	1543	Kidd	T022	C0022645
27834480	1544	1552	variants	T070	C0042333
27834480	1575	1584	structure	T082	C0678594
27834480	1588	1601	Kidd antigens	T116,T129	C0313028
27834480	1610	1618	function	T169	C0542341
27834480	1622	1640	urea transporter-B	T116,T123	C1454327